KIEV, Aug. 30 - U.S. company MaxWell Biocorporation is preparing to launch a drug production facility on the basis of a scientific and industrial cancer and cardiological center under construction in Boryspil in Kiev region, which will be the largest in the CIS and Eastern Europe, the company told Interfax-Ukraine.

The company said that in August, equipment from U.S. company Vanguard Pharmaceutical Machinery for the production of drugs according to GMP standards was supplied to Ukraine. U.S. specialists have started assembling the equipment.